Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.22.2.2
Equity (Tables)
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights The following table summarizes all warrants outstanding as of September 30, 2022:
Expiration Date Exercise Price
 ($)		 Number of Warrants
2023
1.47 - 1.50
 337,500
2024 1.25 35,862,922
2025
1.25 - 3.00
 2,168,508
2026 4.18 300,000
2027 1.93 300,000
2029
0.50 - 2.00
 26,367,627
Total warrants 65,336,557
The following table summarizes the status of warrants and related transactions:
Non-Derivative Warrants
Derivative Warrants (2)
Total Number of Warrants Weighted - Average Exercise Price
Balance as of January 1, 2022
29,156,048 40,124,355 69,280,403 $ 1.19 
Granted 400,000  —  400,000  $ 2.20 
Exercised (1)
(715,846) (3,628,000) (4,343,846) $ 1.26 
Balance as of September 30, 2022
 28,840,202 36,496,355 65,336,557 $ 1.19 
Exercisable as of September 30, 2022
26,940,202 36,496,355 63,436,557 $ 1.15 

(1)The weighted average share price as of the dates of exercise was $3.51. The Company issued 3,176,601 SVS and received $1,179 in cash proceeds during the nine months ended September 30, 2022 for warrants exercised.
(2)Derivative warrants which were issued to the Senior Notes holders and which have an exercise price of $1.25. These warrants represent a derivative liability and are therefore not classified as equity in the statement of financial position. Refer to Note 12 - Derivative Liabilities.